Iovance Biotherapeutics Inc

NASDAQ:IOVA   1:57:12 PM EDT
11.97
-0.41 (-3.31%)
Earnings Announcements

Iovance Biotherapeutics Q2 Loss Per Share $0.63

Published: 08/04/2022 20:42 GMT
Iovance Biotherapeutics Inc (IOVA) - Iovance Biotherapeutics Reports Second Quarter and First Half 2022 Financial Results and Corporate Updates.
Q2 Loss per Share $0.63.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.63

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.65

More details on our Analysts Page.